Alveo Technologies
PrivateLast Round
Grant
May 26, 2026
Total Funding Raised
$60.85M
Company Overview
Alveo Technologies is a biotechnology company that develops a portable, point-of-need molecular diagnostic platform for the rapid detection of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Environmental Monitoring, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alveo Technologies Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Alveo Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 26, 2026 | ||||
| Series A Extension | Apr 29, 2025 | ||||
| Grant | Nov 14, 2024 | ||||
| Series B | Aug 1, 2023 | ||||
| VC Round | Mar 29, 2021 | ||||
Grant | Mar 17, 2021 |
Alveo Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centers for Disease Control and Prevention | Grant |
| CEPI | Grant |
| H. Barton Asset Management | Series A Extension |
| Khosla Ventures | Grant |
| WRVI Capital | Series A, Series A Extension |
| Supply Change Capital | Series A Extension |
| Bill & Melinda Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2025
Raised Series A Extension with Black Diamond Ventures, H. Barton Asset Management, WRVI Capital, and Supply Change Capital.
- Nov 14, 2024
$5.3M grant from the Centers for Disease Control and Prevention.
Alveo Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alveo Technologies's valuation, stock price, and market status.